BioNTech SE - ADR vs Enphase Energy Inc — how do they compare? BioNTech SE - ADR trades at $92.23 (market cap $23.31B), while Enphase Energy Inc trades at $42.58 (market cap $5.41B). The key difference: BioNTech SE - ADR is far larger — about 4.3× Enphase Energy Inc's market cap, and Enphase Energy Inc is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | ENPH | |
|---|---|---|
Market Cap | $23.31B | $5.41B |
Sector | Health | Technology |
52-Week High | $119.34 | $72.33 |
52-Week Low | $83.89 | $26.12 |
Enterprise Value | $6.60B | $5.05B |
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →